Aug 13 (Reuters) - CytomX Therapeutics Inc CTMX.O:
CYTOMX THERAPEUTICS PROVIDES UPDATE ON CX-2051 PHASE 1 STUDY
CYTOMX THERAPEUTICS INC - CTMX-2051-101 STUDY REMAINS ACTIVE WITH CX-2051 DOSING
CYTOMX THERAPEUTICS INC - PHASE 1 DATA UPDATE EXPECTED BY Q1 2026